{
  "compound": "Dronabinol",
  "condition": "NAUSEA_CHEMOTHERAPY",
  "effect_size": "N/A (safety study)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:CINV_OBSERVATIONAL_002",
  "participants": "312 cancer patients on long-term dronabinol",
  "year": 2017,
  "notes": "Long-Term Dronabinol Use in Cancer: 2-Year Safety Study",
  "confidence": "medium",
  "abstract": "Excellent long-term tolerability; no tolerance development for antiemetic effect; sustained nausea control in 74%"
}